GlassScriptPhysician profile
Brent B Campbell
NPI 1326058363
$8,203.35
in general payments reported to CMS, 2019-2025
21 companies · $1,748 in 2025
The $1,748 reported for 2025 was more than what 77% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $806 · 2020: $794 · 2021: $1,853 · 2022: $1,051 · 2023: $1,064 · 2024: $887 · 2025: $1,748.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,500 · Education: $199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,500.24 |
| Education | $198.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $2,407.58 | 2020-2024 | Axonics |
| Janssen Biotech, INC. | $1,242.70 | 2019-2025 | Erleada, Balversa |
| Pfizer INC. | $879.07 | 2019-2025 | |
| Astellas Pharma US INC | $818.81 | 2019-2025 | Xtandi |
| Sumitomo Pharma America, INC. | $640.53 | 2023-2025 | Gemtesa |
| Boston Scientific Corporation | $514.42 | 2020-2025 | General - Erectile Dysfunction, Ams 800 Artificial Urinary Sphincter, Ams 700 |
| Medtronic USA, INC. | $318.01 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $291.12 | 2021-2025 | |
| Procept Biorobotics Corporation | $271.91 | 2023-2025 | Aquabeam Robotic System, Aquabeam System |
| Urovant Sciences INC | $183.25 | 2021-2022 | |
| Medtronic, INC. | $142.63 | 2021-2025 | Interstim |
| Coloplast Corp | $121.32 | 2019-2023 | Titan |
| Tolmar, INC. | $74.36 | 2023-2025 | Jatenzo, Eligard |
| Tolmar Pharmaceuticals, INC. | $63.21 | 2019-2020 | |
| Urogen Pharma, INC. | $50.54 | 2025 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $49.08 | 2021 | |
| Merck Sharp & Dohme LLC | $40.92 | 2021-2023 | Keytruda, Lynparza |
| Teleflex LLC | $31.05 | 2021 | |
| Laborie Medical Technologies Corp. | $26.69 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Amgen INC. | $19.61 | 2019 | |
| Accord Healthcare, INC. | $16.54 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brent Campbell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.